openPR Logo
Press release

Global Pulmonary Function Testing Systems Sales Market to will reach 470 million US$ by 2025

07-25-2018 07:08 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: QY Research, INC.

Global Pulmonary Function Testing Systems Sales Market to will

This report studies the global Pulmonary Function Testing Systems market status and forecast, categorizes the global Pulmonary Function Testing Systems market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Europe's sales volume accounted for the highest market share (28.23%) in 2016, followed by the North America and China.

At present, the manufactures of Pulmonary Function Testing Systems are concentrated in North America, Europe, China and Japan. Europe is the largest production area in the world, which occupied about 31.42% production share in 2016. The global leading players in this market are CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD MGC Diagnostics, etc.

The Pulmonary Function Testing Systems are mainly used by Hospitals, Physical Examination Center and Physician Groups. The dominant application of Pulmonary Function Testing Systems is Hospitals.

In the last few years, the total number of high-tech Pulmonary Function Testing Systems developed by domestic manufacturers is limited. This shows that the efforts to develop high-tech product in China is not enough, but also shows that the allocation space of domestic Pulmonary Function Testing Systems still need to expand. There is still a big gap compared with the imported Pulmonary Function Testing Systems.

Despite the presence of competition problems, as large demand of high-tech products at home and abroad, many companies began to enter the field of high-tech, emergence of technological advancements, investors are still optimistic about this area, the future will still have more new investment enter the field. But it is suggested that enterprises those have plans to enter this industry have careful analysis of this market and the advantages or disadvantages of themselves.

The global Pulmonary Function Testing Systems market is valued at 340 million US$ in 2017 and will reach 470 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2018-2025.

The major players covered in this report

CareFusion(BD)

Schiller

CHEST

COSMED

nSpire Health

NDD

MGC Diagnostics

Minato

Ganshorn

AESRI

Morgan Scientific

M&B

Sikeda

RSDQ

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

United States

Europe

China

Japan

Southeast Asia

India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Portable PFT Systems

Complete PFT Systems

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals

Physical Examination Center

Physician Groups

Other

The study objectives of this report are:

To analyze and study the global Pulmonary Function Testing Systems sales, value, status (2013-2017) and forecast (2018-2025);

To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.

Focuses on the key Pulmonary Function Testing Systems players, to study the sales, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pulmonary Function Testing Systems are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Pulmonary Function Testing Systems Manufacturers

Pulmonary Function Testing Systems Distributors/Traders/Wholesalers

Pulmonary Function Testing Systems Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Pulmonary Function Testing Systems market, by end-use.

Detailed analysis and profiles of additional market players.


Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/61418/global-pulmonary-function-testing-systems-sales-market

About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748 ?
USA: +1 626 295 2442
Email ? enquiry@qyrsearch.com
Web ? www.qyresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pulmonary Function Testing Systems Sales Market to will reach 470 million US$ by 2025 here

News-ID: 1144018 • Views:

More Releases from QY Research, INC.

Through Glass Via (TGV) Interposers Market to Reach US$ 319 Million by 2031, Accelerated by AI/HPC Packaging, mmWave RF Modules, and Advanced Glass Substrate Adoption | QY Research
Through Glass Via (TGV) Interposers Market to Reach US$ 319 Million by 2031, Acc …
Market Summary - The global market for Through Glass Via (TGV) Interposers was estimated to be worth US$ 101 million in 2024 and is forecast to reach a readjusted size of US$ 319 million by 2031, expanding at a robust CAGR of 18.0% during the forecast period 2025-2031. According to QY Research, the newly released report titled "Through Glass Via (TGV) Interposers Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031"
Epinephrine Hydrochloride Injection Market to Reach US$ 5.59 Billion by 2031, Driven by Rising Anaphylaxis Incidence, Emergency Care Demand, and Expanding Global Healthcare Access | QY Research
Epinephrine Hydrochloride Injection Market to Reach US$ 5.59 Billion by 2031, Dr …
Market Summary - The global market for Epinephrine Hydrochloride Injection was estimated to be worth US$ 4,025 million in 2024 and is forecast to reach a readjusted size of US$ 5,592 million by 2031, expanding at a steady CAGR of 4.8% during the forecast period 2025-2031. According to QY Research, the newly released report titled "Epinephrine Hydrochloride Injection Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven
Brushless Drone Motor Market to Reach US$ 3.11 Billion by 2031, Driven by Rapid UAV Commercialization, Industrial Automation, and High-Efficiency Propulsion Demand | QY Research
Brushless Drone Motor Market to Reach US$ 3.11 Billion by 2031, Driven by Rapid …
Market Summary - The global market for Brushless Drone Motor was estimated to be worth US$ 1,074 million in 2024 and is forecast to reach a readjusted size of US$ 3,105 million by 2031, expanding at a strong CAGR of 16.7% during the forecast period 2025-2031. According to QY Research, the newly released report titled "Brushless Drone Motor Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven
Semiconductor Underfill Market to Reach US$ 1.45 Billion by 2031, Driven by Advanced Packaging, 5G Expansion, and Automotive Electronics Reliability Needs | QY Research
Semiconductor Underfill Market to Reach US$ 1.45 Billion by 2031, Driven by Adva …
Market Summary - The global market for Semiconductor Underfill was estimated to be worth US$ 721 million in 2024 and is forecast to reach a readjusted size of US$ 1,445 million by 2031, expanding at a robust CAGR of 10.5% during the forecast period 2025-2031. According to QY Research, the newly released report titled "Semiconductor Underfill Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven assessment of

All 5 Releases


More Releases for Pulmonary

Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments